UTHR
United Therapeutics Corporation
Stock
$541.70−29.68 (−5.19%)Close Oct 2, 2026
- Gross profit, 2025
- $2.8B
- YoY, 2025
- +9.0%
- 5-year CAGR
- +15.3%
- 10-year CAGR
- +7.2%
Gross profit
Gross profit by fiscal year
| Period | Gross profit | YoY |
|---|---|---|
| 2025 | $2.8B | +9.0% |
| 2024 | $2.6B | +24.0% |
| 2023 | $2.1B | +16.0% |
| 2022 | $1.8B | +14.2% |
| 2021 | $1.6B | +13.7% |
| 2020 | $1.4B | +3.3% |
| 2019 | $1.3B | −6.9% |
| 2018 | $1.4B | −11.8% |
| 2017 | $1.6B | +6.1% |
| 2016 | $1.5B | +9.3% |
| 2015 | $1.4B | +21.1% |
| 2014 | $1.2B | +18.2% |
| 2013 | $976M | +24.0% |
| 2012 | $787M | +20.6% |
| 2011 | $652M | +24.5% |
| 2010 | $524M | +65.4% |
| 2009 | $317M | +24.4% |
| 2008 | $255M | — |